COVID-19 and vitamin D status linked to IL-6 and IL-18 levels in children

This cohort study enrolled 170 children aged 1–17 years with PCR-confirmed SARS-CoV-2 infection to examine how COVID-19 and vitamin D status relate to inflammatory cytokine levels during the pandemic. Serum IL-6 and IL-18 were analyzed alongside vitamin D status, with comparisons drawn against healthy controls. The study location was not reported in the abstract.

Children with PCR-confirmed COVID-19 had higher serum IL-6 and IL-18 levels than healthy controls. Within the COVID-19 cohort, children with vitamin D deficiency showed higher cytokine levels than those with normal vitamin D, but these differences did not reach statistical significance. Specific numerical values, effect sizes, and p-values were not reported in the abstract.

Safety and tolerability data were not reported, consistent with the observational design focused on biomarker associations rather than intervention.

Key limitations include the non-significant vitamin D comparisons and the authors' own caveat that the findings do not fully confirm a relationship between low vitamin D and elevated cytokines. The cohort design cannot establish causality, and no information on disease severity stratification, confounder adjustment, or longitudinal follow-up was provided in the abstract.

In clinical practice, these observations are hypothesis-generating. They are consistent with a possible immunomodulatory role for vitamin D in pediatric COVID-19 but do not support changes to supplementation or monitoring practices. The authors call for larger, prospective studies to better characterize the relationship between vitamin D status and inflammatory response in children with SARS-CoV-2 infection.